Search clinical trials for: Iatrogenic opioid abstinence syndrome

Total 44398 results

Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Terminated

Clonidine to Treat Iatrogenic-induced Opioid Dependence in Infants

Neonatal Abstinence Syndrome

United States
Henry Ford Health System

Unknown

Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit

Delirium | Opioid-Induced Disorders | Opioid Use, Unspecified With Withdrawal

United States
USWM, LLC (dba US WorldMeds)
National Institute on Drug Abuse (NIDA)

Recruiting

Pharmacokinetic and Safety Study of Oral Lofexidine in Neonates Experiencing Opioid Withdrawal Due to Intrauterine Exposure to Opioids

Opioid Withdrawal (Disorder)

United States
Milton S. Hershey Medical Center
National Institute on Drug Abuse (NIDA)

Recruiting

MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome

Neonatal Abstinence Syndrome | Neonatal Opioid Withdrawal Syndrome

United States
University of Alberta
Alberta Health services; Alberta Innovates Health Solutions; Covenant Health

Recruiting

The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT Program (NASCENT)

Neonatal Abstinence Syndrome

Canada
Spark Biomedical, Inc.
Medical University of South Carolina; University of Texas Southwestern Medical...

Recruiting

Neurostimulation to Improve NOWS Outcomes (SPROUT)

Neonatal Abstinence Syndrome | Neonatal Opioid Withdrawal Syndrome

United States
Washington State University
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women

Opioid-use Disorder | Neonatal Abstinence Syndrome

United States
Tulane University

Recruiting

The Effect of Music Therapy on Newborns

Neonatal Abstinence Syndrome | Substance Withdrawal, Neonatal

United States
T. John Winhusen, PhD
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Recruiting

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study (MOMs-INO)

Pregnancy Related | Opioid-Related Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Neonatal Abstinence Syndrome | Neonatal Opiate Withdrawal Syndrome | Drug Abuse in Pregnancy

United States
Boston Medical Center
Boston University; Eunice Kennedy Shriver National Institute of Child Health... and other collaborators

Recruiting

MOM NEST Study: Maternal Opioid Medication: Naltrexone Efficacy Study

Pregnancy, High Risk | Alcohol Use Disorder | Opioid-use Disorder | Neonatal Abstinence Syndrome

United States
The Cooper Health System

Recruiting

Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy

Neonatal Abstinence Syndrome

United States
Henrietta Bada
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain (No-POPPY)

Neonatal Abstinence Syndrome

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Maternal Buprenorphine-naloxone Treatment and the Infant

Maternal Opioid Use Disorder | Opioid Exposed Infant

United States
University of Vermont
National Institute on Drug Abuse (NIDA); Johns Hopkins University; University... and other collaborators

Completed

Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions (MOTHER DYAD)

Opioid-use Disorder | Neonatal Abstinence Syndrome | Opioid Withdrawal | Neonatal Opioid Withdrawal Syndrome

United States
Wendy F Hansen
Patient-Centered Outcomes Research Institute

Active, not recruiting

The PATH Home Trial: A Comparative Effectiveness Study of Peripartum Opioid Use Disorder in Rural Kentucky (PATH)

Neonatal Abstinence Syndrome

United States
T. John Winhusen, PhD
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Active, not recruiting

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study (MOMs-CMA)

Pregnancy Related | Opioid-Related Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Neonatal Abstinence Syndrome | Drug Abuse in Pregnancy | Neonatal Opioid Withdrawal Syndrome

United States
Advancing Clinical Trials in Neonatal Opioid Withdrawal...
National Institutes of Health (NIH)

Active, not recruiting

Eating, Sleeping, Consoling for Neonatal Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach ((ESC-NOW))

Neonatal Opiate Withdrawal Syndrome

United States
T. John Winhusen, PhD
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Active, not recruiting

Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs)

Pregnancy Related | Opioid-Related Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Neonatal Abstinence Syndrome | Drug Abuse in Pregnancy | Neonatal Opioid Withdrawal Syndrome

United States
Daniel Benjamin
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care (PTN_POPS)

Heart Failure | Epilepsy | Pain | Pneumonia | Sepsis | Inflammation | Hypertension | Chronic Kidney Diseases | Hemophilia | Schizophrenia | Central Nervous System Infections | Nosocomial Pneumonia | Insomnia | Anxiety | Bipolar Disorder | Neutropenia | Staphylococcal Infections | Bradycardia | Seizures | Urinary Tract Infections | Pulmonary... and other conditions

United States, Canada, United Kingdom, Israel, Singapore
University of Rochester

Completed

Sound Processing Changes in Babies With Opioid Exposure

Neonatal Abstinence Syndrome

United States
Vanderbilt University Medical Center

Completed

Jackson Pediatric Acupressure for Opioid Tapering

Iatrogenic Withdrawal Syndrome

United States
Johns Hopkins All Children's Hospital
Florida Department of Health

Terminated

Methadone Demonstration Project With Neonatal Intensive Care Unit Infants Diagnosed With Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome

United States
Women and Infants Hospital of Rhode Island
National Institute of General Medical Sciences (NIGMS)

Withdrawn

Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)

Neonatal Opioid Withdrawal Syndrome

United States
University of New Mexico

Completed

Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome

United States
Wilkes University

Completed

Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19

COVID-19 | Iatrogenic Disease | ARDS | Withdrawal Syndrome

United States
Indiana University

Completed

Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome | Neonatal Opioid Withdrawal Syndrome | Neonatal Opioid Withdrawal

United States
Wilkes University

Completed

AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU)

Iatrogenic Disease | Withdrawal Syndrome

United States
USWM, LLC (dba US WorldMeds)

Suspended

Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal (TAPER)

Opioid Withdrawal (Disorder)

United States
Thomas Jefferson University
Chiesi Farmaceutici S.p.A.

Completed

Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure (B-PHORE)

Neonatal Abstinence Syndrome | Neonatal Opiate Withdrawal Syndrome

United States
Marc M. Perreault

Completed

Signs and Symptoms of Opioid-associated Iatrogenic Withdrawal in Critically Ill Adults (SOWA-ICU)

Substance Withdrawal Syndrome

Canada
Meharry Medical College
Vanderbilt University Medical Center

Unknown

Averting NAS Among Opioid-Using Young Women Receiving MAT Using Buprenorphine (NAS-MIET)

Contraception | Opioid-use Disorder | Neonatal Abstinence Syndrome

United States
Thomas Jefferson University
National Institute on Drug Abuse (NIDA)

Completed

Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome

United States
University of Zurich

Completed

How to Treat Opiate Withdrawal in Neonates

Neonatal Abstinence Syndrome
Tufts Medical Center

Completed

Improving Outcomes in Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome | Neonatal Opioid Withdrawal

United States
Pediatrix

Completed

Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)

Neonatal Abstinence Syndrome | Neonatal Withdrawal Syndrome

United States
St. Louis University

Completed

Buprenorphine Dose Adjustments and Gestational Age

Neonatal Abstinence Syndrome
University Hospital, Caen

Completed

Interest of Concentrations in Meconium of Buprenorphine and Methadone as a Prognostic Factor of NAS Outcome (SUBOPGEST)

Neonatal Abstinence Syndrome

France
Eastern Maine Medical Center

Completed

Comparison Between Methadone and Morphine for Neonatal Opiate Withdrawal (NAS)

Neonatal Abstinence Syndrome
Johns Hopkins University

Completed

Fetal and Infant Effects of Maternal Buprenorphine Treatment

Neonatal Abstinence Syndrome

United States
Henrietta Bada

Completed

NAS Treatment - Opiate Versus Non-Opiate (NAS)

Neonatal Abstinence Syndrome

United States
Boston Medical Center

Completed

RESPECT-PLUS: Services for Infants With Prenatal Opiate Exposure (RESPECT-Plus)

Child Abuse | Child Development | Opioid Use Disorder | Neonatal Abstinence Syndrome | Child Neglect

United States
Thomas Jefferson University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine for the Treatment of Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Completed

Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome (NAS)

Neonatal Abstinence Syndrome

United States
Thomas Jefferson University

Completed

Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines (MOPPlus)

Neonatal Abstinence Syndrome

United States
London School of Hygiene and Tropical Medicine

Completed

Conflict Between Maternal Autonomy and Child Health in Substance-use

Substance-Related Disorders | Substance Abuse, Intravenous | Alcohol-Related Disorders | Pregnancy | Marijuana Abuse | Opioid-Related Disorders | Cocaine-Related Disorders | Neonatal Abstinence Syndrome | Amphetamine-Related Disorders | Inhalant Abuse | Pregnancy, High-Risk

United Kingdom
Gauda, Estelle B., M.D.
Johns Hopkins University; Johns Hopkins All Children's Hospital

Unknown

Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study

Withdrawal | Drug; Withdrawal Symptoms, Neonatal | Fetus and Newborn Affected by Other Maternal Medication

United States
University of Pittsburgh
National Institute on Drug Abuse (NIDA)

Completed

RCT of High- vs. Standard-Calorie Formula for Methadone-Exposed Infants

Neonatal Abstinence Syndrome

United States
Children's Hospital Medical Center, Cincinnati
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

The Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome

United States
Eastern Maine Medical Center

Completed

Treatment of Neonatal Abstinence Syndrome (HOMENOW)

Neonatal Abstinence Syndrome

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Tobacco Use in Opioid Agonist Treated Pregnant Women (ROSE)

Nicotine Dependence

United States

Search clinical trials for: Iatrogenic opioid abstinence syndrome

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations